… is whether the concentrations achieved by chemosensitizers … -inhibiting activity of
chemosensitizer-containing patient serum. … for monitoring chemosensitizer treatment in cancer …

… Thorough preclinical studies to evaluate key issues such as mechanisms of interaction, …
and whether a patient will benefit from the radiosensitizing or chemosensitizing properties of a …

… in clinical or preclinical development and antisense … oligonucleotides have been evaluated
in models of human … in phase II clinical trials in cancer patients. This present study was …

… ought to be considered as a candidate agent for therapeutic evaluation in AIDS-KS patients.
… Chemosensitization of CCNU in KHT murine tumor cells in vivo and in vitro by the agent RB …

… Preclinical studies have demonstrated synergy … this patient was similar to the intermediate
levels of suppression (60% of baseline) associated with evident chemosensitization in patients …

… Whether this can be utilized to significant advantage in external-beam radiotherapy has
been difficult to definitively demonstrate, with extensive preclinical studies on human tumor …

… xenograft models, or clinical trials in cancer patients. In Biosystems, the combination of two
… effects, and other side effects leading to patient’s death. However, radiosensitizing agents …

… use of anticancer drugs and thus impair patient’s quality of life. … treatment efficiency in cancer
patients and decrease adverse … In the present review, an attempt has been made to gather …

… function in cancer chemotherapy patients. Available evidence … 3 PUFAs is that its
chemosensitizing effect must be substantially … Many preclinical studies used healthy animals to …

… Standard therapy for patients with metastatic pancreatic … Gemcitabine offers clinical benefit
in an adjuvant setting for patients … Evaluation of the chemosensitizing effects of ascorbate and …